Cycowitz Z, Seligsohn U, Zivelin A, Eldor A
Institute of Hematology, Ichilov Hospital, Sourasky-Tel Aviv Medical Center.
Harefuah. 1995 Jul;129(1-2):1-5, 80.
A point mutation in coagulation factor V which causes resistance to cleavage of factor Va by activated protein C (APC), was recently found to underlie thrombotic events. We examined 20 consecutive patients, under the age of 40, who suffered from idiopathic venous or arterial thrombosis. In 8 (40%) there was resistance to APC manifested by absence of the expected prolongation of activated partial thromboplastin time (aPTT). In 3, the addition of normal plasma corrected the anomaly in the patient's plasma, although the addition of factor V- deficient plasma caused no change. In a family of a 17-year-old boy with idiopathic deep venous thrombosis we found a mutation in factor V which was responsible for APC resistance. The patient and 4 family members showed a single G to A transition in position 1691 in their cDNA, resulting in substitution of arginine (506) for glutamine. The mutation in this area, which is the cleavage site for APC, is associated with thrombotic episodes and is frequently observed in patients with familial thrombophilia.
最近发现,凝血因子V中的一个点突变导致活化蛋白C(APC)对因子Va的裂解产生抗性,这是血栓形成事件的基础。我们检查了20例年龄在40岁以下的特发性静脉或动脉血栓形成患者。其中8例(40%)对APC产生抗性,表现为活化部分凝血活酶时间(aPTT)未出现预期延长。3例患者中,加入正常血浆可纠正患者血浆中的异常,而加入因子V缺乏血浆则无变化。在一个患有特发性深静脉血栓形成的17岁男孩的家族中,我们发现了一个导致APC抗性的因子V突变。该患者和4名家庭成员的cDNA在1691位出现了单个G到A的转变,导致精氨酸(506)被谷氨酰胺取代。该区域是APC的裂解位点,此突变与血栓形成发作相关,且在家族性血栓形成倾向患者中经常观察到。